Related references
Note: Only part of the references are listed.TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system
Angela M. Pierce et al.
BRAIN RESEARCH (2014)
Paclitaxel Therapy Promotes Breast Cancer Metastasis in a TLR4-Dependent Manner
Lisa Volk-Draper et al.
CANCER RESEARCH (2014)
Oncogenic roles of EMT-inducing transcription factors
Alain Puisieux et al.
NATURE CELL BIOLOGY (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
Brain tumor senescence might be mediated by downregulation of S-phase kinase-associated protein 2 via butylidenephthalide leading to decreased cell viability
Mao-Hsuan Huang et al.
TUMOR BIOLOGY (2014)
TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Sandeep Rajput et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Butylidenephthalide Suppresses Human Telomerase Reverse Transcriptase (TERT) in Human Glioblastomas
Po-Cheng Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas
Horng-Jyh Harn et al.
NEURO-ONCOLOGY (2011)
Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis A review
Abraham Tsitlakidis et al.
JOURNAL OF NEUROSURGERY (2010)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Integration of cytokine and heterologous receptor signaling pathways
Jelena S. Bezbradica et al.
NATURE IMMUNOLOGY (2009)
Axl and growth arrest - Specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme
Markus Hutterer et al.
CLINICAL CANCER RESEARCH (2008)
Orphan nuclear receptor, Nurr-77 was a possible target gene of butylidenephthalide chemotherapy on glioblastoma multiform brain tumor
Po-Cheng Lin et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Direct repression of cyclin d1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition
Jakob Mejlvang et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3
Nu-Man Tsai et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
P Vajkoczy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo
NM Tsai et al.
CLINICAL CANCER RESEARCH (2005)
Cost of migration: Invasion of malignant gliomas and implications for treatment
A Giese et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
